HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,275,000 | +3.8% | 34,092 | -3.1% | 0.02% | 0.0% |
Q3 2014 | $1,228,000 | -13.0% | 35,176 | -12.1% | 0.02% | -8.0% |
Q2 2014 | $1,411,000 | +10.7% | 40,021 | +2.3% | 0.02% | +4.2% |
Q1 2014 | $1,275,000 | -38.0% | 39,116 | -19.8% | 0.02% | -29.4% |
Q4 2013 | $2,056,000 | -4.6% | 48,791 | -9.7% | 0.03% | -17.1% |
Q3 2013 | $2,155,000 | +0.5% | 54,057 | +4.3% | 0.04% | -10.9% |
Q2 2013 | $2,145,000 | – | 51,850 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |